David C. Silvious
Analyst · Robert. W. Baird. Please state your question
All right, thanks, Steve, thanks to each of you for joining us this morning. Our net sales for the quarter were $252.1 million compared to $247.8 million in Q3 of ‘16. That is a 1.7% increase or $4.3 million increase. Recall that on October 2, we announced that we would incur a charge related to new additional investment in the two wood pellet plants, so we have delivered to Georgia and Arkansas. This charge resulted in an impact on EPS for the quarter and year-to-date of $0.59 per share and I’ll discuss that a little later. But throughout my comments I will refer to this charge as the impact of new pellet investment. For comparative purposes, I will also be discussing the impact of all pellet plant activity during the periods under discussion. The new pellet investment is a component of that all or total pellet activity in Q3 of 2017. So without the impact of that new pellet charge for the quarter, net sales were $266.3 million for Q3 of 2017. That charge impacted sales because we are on a percentage of completion basis on the Arkansas pellet plant. Without the impact of all pellet plant activity during the quarter, which includes the charge I mentioned, net sales were $265.5 million for Q3 of ‘17, and $228.6 million for Q3 of ‘16. That’s an increase of $36.9 million or 16.1% increase in the core business. International sales were $55.6 million this quarter compared to $47.9 million in Q3 ‘16, a 16% increase or $7.7 million increase. International sales represented 22% of sales in this quarter compared to 19.3% in the same quarter last year. The increase in international sales for Q3 of 2017 compared to the same quarter last year, primarily in Canada and Brazil, the Middle East and Asia. Those increases were offset by decreases in Mexico, and Central America outside of Brazil, in Europe and the West Indies. For the quarter international sales increased in each of our groups. Domestic sales were $196.5 million in this quarter compared to $199.9 million in Q3 ‘16, a decrease of 1.7% or $3.4 million decrease. Without the impact of the charge for the new pellet investment, domestic sales were $210.7 million for Q3 of 2017. And without the impact of all pellet plant activity during this quarter and the same quarter last year, domestic sales were $209.9 million this year compared to Q3 2016 domestic sales of $180.8 million. That’s an increase of $29.1 million or a 16.1% increase in domestic sales for the core business. For the quarter domestic sales increased in the Agg and Mining Group and decrease in the Infrastructure Group and the Energy Group. Part sales were $64.3 million this quarter compared to $63.1 million in Q3 of ‘16, a $1.2 million or 1.9% increase. Part sales for each of the Q3 ‘17 and Q3 ‘16 periods represented 25.5% of total sales. For the quarter, part sales increased in the Agg and Mining Group and decrease in Infrastructure and Energy Groups. Foreign exchange translation had a positive impact on sales for the quarter of $1 million that is if rates this year were equal to last year’s rates, sales would have been $1 million lower this year. Net sales for the year were $872.4 million compared to $820.9 million for the same period last year. That’s an increase of 6.3% or $51.5 million increase. Without the impact of the previously announced new pellet plant investments, net sales were $886.6 million for the first nine months of ‘17, again sales were impacted by that new pellet plant charge because we are on a percentage of completion basis of accounting for the Arkansas pellet plant. Without the impact of all pellet plant activity for the first nine months this year and last year, net sales were $870 million this year compared to $756.3 million last year, an increase of $113.7 million or 15% increase in the core business. International sales were $185.5 million compared to $144.6 million for the year-to-date period last year, a 28.3% or $40.9 million increase. Those increases occurred primarily in Canada and Russia and Australia, Brazil and in Asia. These were offset by decreases in South America outside of Brazil, in Japan and in Central America. International sales represented 21.3% of sales for the first nine months of ‘17 compared to 17.6% of total sales for the first nine months of '16. For the year, our international sales increased in each of our groups. Domestic sales were $686.9 million for the first nine months of this year compared to $676.3 million for the same period of last year, a 1.6% increase or $10.6 million increase. Again without the impact of new pellet investment, domestic sales were $701.1 million for the year-to-date period in '17 and without the impact of all pellet plant activity during the first nine months of this year and last year, domestic sales were $684.5 million this year compared to $611.7 million last year. That’s an increase of $72.8 million or 11.9% increase. Year-to-date, domestic sales were 78.7% of total sales this year compared to 82.4% last year. Part sales for the year were $214.1 million compared to $201 million last year for an increase of 6.5% or $13.1 million. Part sales were 24.5% of total sales for both the first nine months of this year and last year. Again foreign exchange translation had a positive impact on sales for the year-to-date period of $1.4 million that is if rates this year were equal to rates last year sales would have been $1.4 million lower. Gross profit for the quarter was $39.1 million compared to $55.4 million in Q3 of '16 a decrease of 29.4% or $16.3 million decrease. The gross profit percentage then was 15.5% for the quarter compared to 22.4% for Q3 of '16.Without the impact of the new pellet plant charges, the gross profit percentage would have been 22.6% and without the impact of all pellet plant activity during this quarter and the same quarter last year, the gross profit percentage would have been 23.3% for Q3 of '17 and 21.1% for Q3 of '16. The absorption variance for Q3 of '17 was $200,000 under absorbed compared to a $6 million under absorption variance for Q3 of '16. That makes a positive change in the absorption variance of $5.8 million. On a year-to-date basis, gross profit was $180.4 million compared to $200.8 million for the first nine months of last year, a decrease of 10.2% or $20.4 million decrease. Gross profit percentage then is 20.7% compared to 24.5% for the first nine months last year. And without the impact again of the new pellet investment on the year-to-date period, gross profit would have been 22.7%, and without the impact of all pellet plant activity during the first nine months of this year and last year, the gross profit percentage is 23.9% this year compared to 23.5% for the first nine months of '16. The absorption variance for the first nine months of this year is $2.5 million over absorbed compared to $7.5 million under absorbed in '16, a $10 million positive change in the absorption variance. SGA&E for the quarter was $45.5 million or 18% of sales compared to $44 million or 17.7% of sales in Q3 of '16, $1.5 million increase, or 30 basis points increase and the drivers of that $1.5 million are additional research and development cost or expenses of about $900,000 of additional health insurance over Q3 last year of about $600,000. For the year, SGA&E was $142.8 million or 16.4% of sales, compared to $132.7 million or 16.2% of sales last year. That’s a $10.1 million increase or an increase of 20 basis points as a percentage of sales. The year-over-year increases occurred in ConExpo, recall that we had ConExpo earlier this year that was about $4.6 million, we did not have that in 2016. And additional payroll and related cost and benefits of about $5.6 million in the current year over the first nine-months of last year. Operating income or loss was $6.4 million of loss in Q3 of ‘17, compared to $11.4 million of earnings in Q3 of ‘16. That’s a decrease of 156% or $17.8 million decrease in operating income. Without the impact of the new charges for pellet plant investment during the quarter, operating income was $14.6 million, and without all pellet plant activity in the current quarter and in the same quarter last year, operating income was $16.3 million for Q3 of ‘17, compared to $4.3 million for Q3 of ‘16. That’s a $12 million increase or 281% increase in operating income in the core business for the quarter. On a year-to-date basis, $37.5 million was our operating income, compared to $68.1 million for the year-to-date period in ‘16, a 44.9% or $30.6 million decrease. Without the impact of new pellet plant investment during the year, operating income was $58.6 million, and without all pellet plant activity during this year and last year, operating income was $64.6 million for the first nine months of ‘17, compared to $45.3 million for the first nine months of ‘16, an increase of $19.3 million or 42.8% increase in operating income of the core business. The effective tax rate is a little high this quarter, it’s 50.7% compared to 41.5% last year, and it’s 31.1% on a year-to-date basis, compared to 37.6% on a year-to-date basis last year. And the drivers for the quarter and the year are the same, except that we had a loss during the quarter, and we’ve earnings for the year-to-date. So, the drivers for the high tax return in the quarter and the low tax rate were a combination of the pre-tax loss in the quarter that we incurred along with increased research and development credits in 2017 as oppose to 2016. Benefits from changes in Tennessee tax law that reduced our tax burden in the state and a favorable adjustment related to our federal income tax filing for 2016, which recently filed. Net income attributable to controlling interest, so we had a net loss for the quarter of $2.7 million, compared to $6.8 million of income in Q3 of ‘16, a decrease of 139.7% or $9.5 million decrease in net income. Earnings per share for the quarter was a $0.12 loss per share, compared to $0.30 earnings for Q3 of ’16, a 140% decrease or $0.42 per share decrease in EPS for the quarter. Without the impact of the charge for new pellet plant investment during the quarter, net income was $11 million, or $0.47 per diluted share. This means that the negative impact of the new pellet plant investment on the quarter and year-to-date was $0.59 per diluted share, $0.01 above the range we estimated in our October 2, press release. That’s due to the estimate that we used for our September actual cost to be incurred. So, as we built out $0.54 to $0.58 per share estimate we had to estimate September cost to actually be incurred because we’re on percentage of completion at the one plant in Arkansas. And we had to estimate the tax impact on the charges for both Georgia and Arkansas. And so those estimates came in a little different when the actual numbers came rolling in and so we were off by $0.01 off of that range. Without the impact of all pellet plant activity during the quarter net income was $12.1 million or $0.52 per share for Q3 of ‘17 and $2.4 million or $0.10 per share for Q3 of ‘16 ex-pellets in both periods. That’s an increase of $9.7 million or over 400% increase in earnings ex-pellets. So the core business earnings per share increased $0.42 per diluted share quarter-over-quarter. Year-to-date net income was $26.9 million compared to $42.8 million for the year-to-date 2016 period, a decrease of 37.1% or $15.9 million decrease. Earnings per share were $1.16 for the year-to-date period compared to $1.85 for the year-to-date period in ‘16, so a decrease of 37.3% or $0.69 per share. Again the new pellet investment during the year-to-date period was had an impact on the year-to-date period of $0.59 per share. But without that new charge net income would have been for the first nine months $40.5 million or $1.75 per diluted share. Without the impact of all pellet plan activity during the first nine months this year and last net income was $44.4 million or $1.92 for year-to-date 2017 and $28.3 million or $1.22 for year-to-date 2016, an increase of $16.1 million or 56.8% increase. So the core business earnings per share increased $0.69 per diluted share for the year-to-date 2017 versus the year-to-date 2016. EBITDA during the quarter was $400,000 compared to $18.1 million for Q3 of ‘16, a decrease of 97.8% or $17.7 million decrease in EBITDA. Without new pellet plant charges for the quarter EBITDA would have been $21.4 million. And without the impact of all pellet plant activity in the quarters this year and last EBITDA for this year’s quarter would have been $23.1 million compared to $11 million in Q3 of ‘16, a $12.1 million increase or 110% increase. EBITDA year-to-date was $57.7 million compared to $87 million for the year-to-date period last year, 33.7% or $29.3 million decrease in EBITDA year-over-year. Without the impact of new pellet investment during the first nine months of ‘17 EBITDA was $78.7 million. And without the impact of all pellets this year and last year EBITDA was $84.8 million for 2017 and $64.2 million for 2016, an increase of $20.6 million or 32.1% increase in EBITDA from the core business. Total backlog was $385.5 million at 9/30 of this year compared to $389.3 million at the same date last year. A $3.8 million or 1% decrease in total backlog. International backlog at 9/30 of this year was $76 million compared to $63.7 million at the same date last year, an increase of $12.3 million or 19.3%. Domestic backlog at 9/30 of this year was $309.5 million compared to $325.6 million at 9/30 of ‘16 a decrease of $16.1 million or a 4.9% decrease in domestic backlog. Excluding pellet plant backlogs, the 9/30/2017 backlog increased $61.1 million or 25% compared to the September 30, 2016 backlog. Moving to the balance sheet, our balance sheet continues to be very strong. We have receivables of $109.7 million compared to $111.8 million at this date last year. Days outstanding were 38.9 at September 30, compared to 40.9 at September 30 of ‘16. And our inventory is $399.3 million this year compared to $399.7 million or a slight decrease year-over-year, but our turns are at 2.5 turns this year compared to 2 turns last year. We owe nothing on our $100 million domestic credit facility and we have at 9/30/2017 $68 million in cash and investments. Letters of credit outstanding are $8.6 million at September 30, yielding a borrowing availability of $91.4 million on our credit line. In Brazil, we currently have about $5 million of debt used to finance that company’s building fixtures and inventory. CapEx for the quarter was $2.9 million and for the year CapEx was $14.4 million. For 2017 we’re forecasting CapEx to be approximately $22 million. Depreciation for the quarter was $5.3 million and $15.9 million for the year. For 2017 full year we’re forecasting depreciation to be around $22 million. So that concludes my prepared remarks on the financial details. I’ll turn it back over to Steve Anderson.